Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
More in Economy
F&O Talk: Big break above 23,200 can open doors for 23,500 for Nifty; Sudeep Shah picks 6 stocks ahead of Diwali
October 31, 2026
IPO ahead: Value-fashion retailer Ratnadeep Retail gets Sebi nod to raise funds through public issue
October 31, 2026
Diwali stock picks: SBI Securities lists 11 stocks with up to 22% upside potential. Do you own any?
October 31, 2026
Oil prices soar 14% in October to end at 6-month high as US weighs fresh attacks after midterm elections. More upside ahead?
October 31, 2026
LIC Housing Fin Q2 net profit grows 12% YoY
October 31, 2026
New India slips into red with 1,267 cr loss in Q2
October 31, 2026
Latest News
Hakimi’s hat-trick guides PSG to stunning 5-1 win at Le Havre in Ligue 1
October 31, 2026
US, South Korea, Japan call for ‘complete denuclearisation’ of North Korea
October 31, 2026
US midterms: 3 days to go – What latest polls say as early voting surges
October 31, 2026
Canada’s in-form Leylah Fernandez reaches Pan Pacific Open final in Tokyo
October 31, 2026
F&O Talk: Big break above 23,200 can open doors for 23,500 for Nifty; Sudeep Shah picks 6 stocks ahead of Diwali
October 31, 2026
LeBron James, Tyrese Maxey shine as 76ers beat Knicks in NBA Cup thriller
October 31, 2026